Concepts (325)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thalamus | 53 | 2020 | 132 | 13.510 |
Why?
|
| Geniculate Bodies | 108 | 2019 | 140 | 10.110 |
Why?
|
| Cerebral Cortex | 29 | 2021 | 584 | 6.360 |
Why?
|
| Neural Pathways | 44 | 2020 | 308 | 5.730 |
Why?
|
| Somatosensory Cortex | 19 | 2019 | 129 | 5.490 |
Why?
|
| Neurons | 68 | 2019 | 1546 | 5.110 |
Why?
|
| Auditory Cortex | 13 | 2018 | 58 | 4.540 |
Why?
|
| Thalamic Nuclei | 18 | 2017 | 32 | 4.530 |
Why?
|
| Synapses | 34 | 2018 | 265 | 4.450 |
Why?
|
| Receptors, Metabotropic Glutamate | 17 | 2015 | 52 | 4.200 |
Why?
|
| Visual Cortex | 40 | 2018 | 251 | 3.360 |
Why?
|
| Cats | 104 | 2007 | 303 | 3.290 |
Why?
|
| Nerve Net | 14 | 2021 | 366 | 3.210 |
Why?
|
| Visual Pathways | 55 | 2018 | 152 | 3.150 |
Why?
|
| Neural Inhibition | 18 | 2015 | 97 | 2.590 |
Why?
|
| Brain Mapping | 28 | 2017 | 548 | 2.270 |
Why?
|
| Animals | 181 | 2021 | 26582 | 2.260 |
Why?
|
| Axons | 27 | 2011 | 174 | 2.200 |
Why?
|
| Mice, Inbred BALB C | 27 | 2015 | 1047 | 2.200 |
Why?
|
| Synaptic Transmission | 19 | 2014 | 222 | 2.010 |
Why?
|
| In Vitro Techniques | 27 | 2017 | 989 | 1.750 |
Why?
|
| Photic Stimulation | 29 | 2015 | 493 | 1.670 |
Why?
|
| Interneurons | 15 | 2015 | 93 | 1.650 |
Why?
|
| Excitatory Postsynaptic Potentials | 15 | 2013 | 87 | 1.620 |
Why?
|
| Patch-Clamp Techniques | 22 | 2019 | 396 | 1.610 |
Why?
|
| Electric Stimulation | 33 | 2019 | 347 | 1.560 |
Why?
|
| Auditory Pathways | 5 | 2012 | 33 | 1.520 |
Why?
|
| Glutamic Acid | 12 | 2016 | 152 | 1.490 |
Why?
|
| Retina | 29 | 2013 | 213 | 1.470 |
Why?
|
| Mice | 36 | 2020 | 11352 | 1.430 |
Why?
|
| Action Potentials | 28 | 2015 | 573 | 1.420 |
Why?
|
| Efferent Pathways | 6 | 2018 | 21 | 1.380 |
Why?
|
| Brain Stem | 12 | 2002 | 165 | 1.100 |
Why?
|
| Vision, Ocular | 20 | 2005 | 71 | 1.030 |
Why?
|
| Afferent Pathways | 11 | 2013 | 77 | 1.010 |
Why?
|
| GABAergic Neurons | 2 | 2015 | 16 | 1.000 |
Why?
|
| Visual Perception | 25 | 2003 | 319 | 0.930 |
Why?
|
| Behavior | 2 | 2021 | 85 | 0.900 |
Why?
|
| Ventral Thalamic Nuclei | 2 | 2015 | 6 | 0.890 |
Why?
|
| Feedback, Physiological | 3 | 2013 | 62 | 0.860 |
Why?
|
| Presynaptic Terminals | 5 | 2018 | 40 | 0.860 |
Why?
|
| Dendrites | 17 | 2010 | 99 | 0.850 |
Why?
|
| Sensory Deprivation | 23 | 2001 | 31 | 0.820 |
Why?
|
| Cognition | 3 | 2019 | 570 | 0.800 |
Why?
|
| Flavoproteins | 5 | 2011 | 25 | 0.770 |
Why?
|
| Neurosciences | 2 | 2018 | 52 | 0.740 |
Why?
|
| Electrophysiology | 26 | 2008 | 401 | 0.690 |
Why?
|
| Mesencephalon | 4 | 2010 | 64 | 0.680 |
Why?
|
| Sensorimotor Cortex | 1 | 2018 | 11 | 0.670 |
Why?
|
| Animals, Newborn | 12 | 2015 | 510 | 0.660 |
Why?
|
| Calcium | 13 | 2009 | 1156 | 0.660 |
Why?
|
| Models, Neurological | 10 | 2013 | 405 | 0.660 |
Why?
|
| Microscopy, Fluorescence | 5 | 2011 | 425 | 0.660 |
Why?
|
| Executive Function | 1 | 2019 | 86 | 0.660 |
Why?
|
| Attention | 2 | 2021 | 388 | 0.640 |
Why?
|
| Excitatory Amino Acid Antagonists | 8 | 2012 | 78 | 0.630 |
Why?
|
| Lasers | 4 | 2011 | 106 | 0.610 |
Why?
|
| Superior Colliculi | 9 | 2009 | 20 | 0.600 |
Why?
|
| Macaca mulatta | 6 | 2003 | 459 | 0.600 |
Why?
|
| Inhibitory Postsynaptic Potentials | 3 | 2015 | 20 | 0.600 |
Why?
|
| Synaptic Potentials | 3 | 2011 | 15 | 0.590 |
Why?
|
| Prosencephalon | 3 | 2013 | 62 | 0.580 |
Why?
|
| Motor Cortex | 2 | 2018 | 195 | 0.580 |
Why?
|
| GABA Antagonists | 7 | 2011 | 25 | 0.570 |
Why?
|
| Intralaminar Thalamic Nuclei | 3 | 2005 | 7 | 0.560 |
Why?
|
| Behavior, Animal | 4 | 2021 | 373 | 0.560 |
Why?
|
| Cycloleucine | 5 | 2003 | 10 | 0.560 |
Why?
|
| gamma-Aminobutyric Acid | 9 | 2007 | 83 | 0.540 |
Why?
|
| Membrane Potentials | 15 | 2009 | 435 | 0.520 |
Why?
|
| Nerve Endings | 9 | 2010 | 16 | 0.500 |
Why?
|
| Brain | 4 | 2021 | 2216 | 0.500 |
Why?
|
| Connectome | 1 | 2015 | 74 | 0.480 |
Why?
|
| Calcium Channels | 5 | 2005 | 182 | 0.480 |
Why?
|
| Biological Evolution | 1 | 2021 | 919 | 0.470 |
Why?
|
| Retinal Ganglion Cells | 7 | 1995 | 66 | 0.460 |
Why?
|
| Excitatory Amino Acid Agonists | 4 | 2013 | 45 | 0.410 |
Why?
|
| Male | 21 | 2023 | 40967 | 0.390 |
Why?
|
| Neuronal Plasticity | 4 | 2014 | 187 | 0.380 |
Why?
|
| Rats | 11 | 2009 | 3990 | 0.370 |
Why?
|
| Microscopy, Electron | 13 | 2004 | 503 | 0.370 |
Why?
|
| Pulvinar | 3 | 2005 | 3 | 0.370 |
Why?
|
| Visual Fields | 24 | 1995 | 98 | 0.370 |
Why?
|
| Cholinergic Fibers | 1 | 2010 | 23 | 0.370 |
Why?
|
| Receptors, Muscarinic | 2 | 2007 | 49 | 0.360 |
Why?
|
| Female | 20 | 2023 | 44534 | 0.360 |
Why?
|
| S100 Calcium Binding Protein G | 1 | 2009 | 22 | 0.360 |
Why?
|
| Anterior Thalamic Nuclei | 1 | 2009 | 2 | 0.350 |
Why?
|
| Tetrodotoxin | 6 | 2007 | 50 | 0.350 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2009 | 68 | 0.350 |
Why?
|
| Electrophysiological Phenomena | 3 | 2018 | 49 | 0.350 |
Why?
|
| Sensory Receptor Cells | 1 | 2009 | 35 | 0.340 |
Why?
|
| Biotin | 2 | 2008 | 44 | 0.330 |
Why?
|
| Lateral Thalamic Nuclei | 2 | 2005 | 4 | 0.330 |
Why?
|
| Immunohistochemistry | 9 | 2012 | 1753 | 0.320 |
Why?
|
| Neurotransmitter Agents | 2 | 2017 | 106 | 0.320 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2009 | 1219 | 0.320 |
Why?
|
| Mice, Transgenic | 3 | 2020 | 1540 | 0.310 |
Why?
|
| Serotonin | 2 | 2008 | 218 | 0.310 |
Why?
|
| Reticular Formation | 2 | 2006 | 17 | 0.310 |
Why?
|
| Sensation | 1 | 2007 | 45 | 0.300 |
Why?
|
| Optogenetics | 2 | 2018 | 30 | 0.290 |
Why?
|
| Olfactory Pathways | 1 | 2006 | 23 | 0.290 |
Why?
|
| Reaction Time | 9 | 2001 | 309 | 0.290 |
Why?
|
| Neurons, Afferent | 6 | 2010 | 79 | 0.270 |
Why?
|
| Humans | 24 | 2023 | 86645 | 0.270 |
Why?
|
| Functional Laterality | 12 | 1988 | 201 | 0.250 |
Why?
|
| Methacholine Chloride | 3 | 2010 | 64 | 0.250 |
Why?
|
| Saccades | 2 | 2003 | 69 | 0.250 |
Why?
|
| Evoked Potentials | 12 | 2002 | 190 | 0.240 |
Why?
|
| Orientation | 8 | 2000 | 119 | 0.240 |
Why?
|
| Computer Simulation | 4 | 2002 | 1078 | 0.230 |
Why?
|
| Horseradish Peroxidase | 12 | 1995 | 35 | 0.230 |
Why?
|
| Pyramidal Cells | 2 | 2018 | 80 | 0.230 |
Why?
|
| Microscopy, Confocal | 2 | 2015 | 268 | 0.230 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2015 | 1204 | 0.230 |
Why?
|
| Pyridazines | 3 | 2009 | 22 | 0.230 |
Why?
|
| Models, Biological | 2 | 2008 | 1749 | 0.220 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 3092 | 0.220 |
Why?
|
| Indomethacin | 2 | 2013 | 59 | 0.220 |
Why?
|
| Muscarinic Agonists | 3 | 2010 | 23 | 0.220 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 2 | 2013 | 62 | 0.220 |
Why?
|
| Electroencephalography | 3 | 2003 | 709 | 0.210 |
Why?
|
| Pancreatitis | 2 | 2013 | 87 | 0.210 |
Why?
|
| Optic Chiasm | 10 | 1991 | 16 | 0.210 |
Why?
|
| Evoked Potentials, Visual | 5 | 1995 | 87 | 0.210 |
Why?
|
| Biophysics | 3 | 2011 | 152 | 0.210 |
Why?
|
| Acetylcholine | 3 | 2000 | 176 | 0.200 |
Why?
|
| Cognitive Dysfunction | 1 | 2023 | 132 | 0.200 |
Why?
|
| GABA-A Receptor Antagonists | 2 | 2013 | 15 | 0.190 |
Why?
|
| Fluorescence | 2 | 2011 | 102 | 0.190 |
Why?
|
| Mediodorsal Thalamic Nucleus | 1 | 2019 | 1 | 0.180 |
Why?
|
| Feedback | 2 | 2006 | 133 | 0.180 |
Why?
|
| Receptors, AMPA | 3 | 2009 | 66 | 0.180 |
Why?
|
| Time Factors | 9 | 2012 | 5210 | 0.180 |
Why?
|
| Alzheimer Disease | 1 | 2023 | 470 | 0.170 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2009 | 87 | 0.160 |
Why?
|
| Transgender Persons | 1 | 2020 | 95 | 0.160 |
Why?
|
| Phosphinic Acids | 2 | 2009 | 4 | 0.160 |
Why?
|
| ROC Curve | 2 | 2002 | 752 | 0.160 |
Why?
|
| Cholinergic Agents | 1 | 1997 | 17 | 0.150 |
Why?
|
| Pre-Exposure Prophylaxis | 1 | 2020 | 137 | 0.150 |
Why?
|
| History, 21st Century | 1 | 2018 | 175 | 0.150 |
Why?
|
| Basal Ganglia | 1 | 2017 | 42 | 0.150 |
Why?
|
| Fluorescent Dyes | 2 | 2012 | 242 | 0.150 |
Why?
|
| History, 20th Century | 1 | 2018 | 312 | 0.140 |
Why?
|
| Dextrans | 2 | 2008 | 77 | 0.140 |
Why?
|
| Space Perception | 6 | 1992 | 115 | 0.130 |
Why?
|
| Microelectrodes | 3 | 2004 | 81 | 0.130 |
Why?
|
| Cell Count | 3 | 2012 | 195 | 0.130 |
Why?
|
| Cells, Cultured | 2 | 2014 | 2818 | 0.120 |
Why?
|
| Rhodopsin | 1 | 2013 | 19 | 0.120 |
Why?
|
| Decision Making | 1 | 2019 | 642 | 0.120 |
Why?
|
| Dominance, Cerebral | 5 | 1983 | 66 | 0.120 |
Why?
|
| Glutamates | 2 | 2010 | 89 | 0.120 |
Why?
|
| Resorcinols | 1 | 2013 | 5 | 0.120 |
Why?
|
| Receptors, Ionotropic Glutamate | 1 | 2013 | 1 | 0.120 |
Why?
|
| Schizophrenia | 1 | 2017 | 464 | 0.120 |
Why?
|
| Cyclopropanes | 1 | 2013 | 25 | 0.110 |
Why?
|
| Luminescent Proteins | 1 | 2013 | 144 | 0.110 |
Why?
|
| Optic Nerve | 2 | 1988 | 35 | 0.110 |
Why?
|
| Lysine | 3 | 2001 | 147 | 0.110 |
Why?
|
| Glycine | 1 | 2013 | 92 | 0.110 |
Why?
|
| Axonal Transport | 4 | 1997 | 31 | 0.110 |
Why?
|
| Photolysis | 1 | 2012 | 13 | 0.110 |
Why?
|
| Adenoviridae | 1 | 2013 | 345 | 0.110 |
Why?
|
| Parasympathetic Nervous System | 2 | 2007 | 33 | 0.110 |
Why?
|
| Stilbenes | 1 | 2011 | 25 | 0.100 |
Why?
|
| Transfection | 1 | 2013 | 896 | 0.100 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 2 | 2009 | 14 | 0.100 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2013 | 557 | 0.100 |
Why?
|
| Algorithms | 3 | 2011 | 1830 | 0.100 |
Why?
|
| Brain Diseases | 1 | 2013 | 180 | 0.100 |
Why?
|
| HIV Infections | 1 | 2020 | 772 | 0.100 |
Why?
|
| Perfusion | 1 | 2012 | 203 | 0.100 |
Why?
|
| Sensory Thresholds | 4 | 2001 | 54 | 0.100 |
Why?
|
| Amblyopia | 2 | 1982 | 7 | 0.100 |
Why?
|
| Receptors, Neurotransmitter | 1 | 1990 | 25 | 0.090 |
Why?
|
| Stents | 1 | 2013 | 377 | 0.090 |
Why?
|
| Receptors, GABA-B | 1 | 2009 | 7 | 0.090 |
Why?
|
| Ultraviolet Rays | 1 | 2011 | 193 | 0.090 |
Why?
|
| Receptors, GABA-A | 1 | 2009 | 32 | 0.090 |
Why?
|
| Homeostasis | 1 | 2012 | 409 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 243 | 0.090 |
Why?
|
| Calbindin 2 | 1 | 2009 | 5 | 0.090 |
Why?
|
| Calbindins | 1 | 2009 | 19 | 0.090 |
Why?
|
| Electron-Transferring Flavoproteins | 1 | 2009 | 2 | 0.090 |
Why?
|
| Quinoxalines | 1 | 2009 | 50 | 0.090 |
Why?
|
| Dioxolanes | 1 | 2009 | 8 | 0.090 |
Why?
|
| Models, Animal | 1 | 2010 | 263 | 0.090 |
Why?
|
| Receptors, GABA | 1 | 2009 | 10 | 0.090 |
Why?
|
| Purines | 1 | 2009 | 91 | 0.080 |
Why?
|
| Staining and Labeling | 2 | 2008 | 165 | 0.080 |
Why?
|
| Anesthesia | 3 | 2000 | 164 | 0.080 |
Why?
|
| Models, Anatomic | 1 | 2009 | 91 | 0.080 |
Why?
|
| Dizocilpine Maleate | 1 | 2008 | 12 | 0.080 |
Why?
|
| Nitric Oxide Synthase | 2 | 2000 | 125 | 0.080 |
Why?
|
| Electron Transport Complex IV | 1 | 2008 | 47 | 0.080 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2008 | 188 | 0.080 |
Why?
|
| Ocular Physiological Phenomena | 3 | 1977 | 11 | 0.080 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2009 | 201 | 0.080 |
Why?
|
| Time Perception | 3 | 1982 | 24 | 0.080 |
Why?
|
| Bacterial Proteins | 1 | 2013 | 864 | 0.080 |
Why?
|
| Calcium-Binding Proteins | 1 | 2008 | 115 | 0.080 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2007 | 29 | 0.080 |
Why?
|
| Auditory Perception | 1 | 2008 | 96 | 0.070 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2007 | 134 | 0.070 |
Why?
|
| Macaca | 2 | 2005 | 87 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2009 | 912 | 0.070 |
Why?
|
| Phytohemagglutinins | 3 | 1991 | 22 | 0.070 |
Why?
|
| Smell | 1 | 2006 | 109 | 0.070 |
Why?
|
| Gap Junctions | 1 | 2006 | 142 | 0.070 |
Why?
|
| Diagnostic Imaging | 1 | 2009 | 469 | 0.070 |
Why?
|
| Wakefulness | 2 | 2003 | 134 | 0.070 |
Why?
|
| Drug Interactions | 1 | 2005 | 248 | 0.060 |
Why?
|
| Cell Size | 1 | 2005 | 65 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 1 | 2006 | 297 | 0.060 |
Why?
|
| Macaca fascicularis | 2 | 2001 | 108 | 0.060 |
Why?
|
| Learning | 2 | 2014 | 280 | 0.060 |
Why?
|
| Potassium | 2 | 2001 | 281 | 0.060 |
Why?
|
| Fourier Analysis | 3 | 2009 | 125 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 1961 | 0.060 |
Why?
|
| Injections | 1 | 2003 | 109 | 0.060 |
Why?
|
| Differential Threshold | 2 | 2000 | 12 | 0.060 |
Why?
|
| Administration, Rectal | 2 | 2013 | 12 | 0.060 |
Why?
|
| Neural Conduction | 5 | 1985 | 69 | 0.050 |
Why?
|
| Motion Perception | 5 | 1991 | 105 | 0.050 |
Why?
|
| Electrodes, Implanted | 1 | 2003 | 171 | 0.050 |
Why?
|
| Vision Disorders | 1 | 1982 | 75 | 0.050 |
Why?
|
| Microinjections | 2 | 1995 | 70 | 0.050 |
Why?
|
| Pattern Recognition, Visual | 2 | 2000 | 151 | 0.050 |
Why?
|
| Aging | 2 | 2023 | 691 | 0.050 |
Why?
|
| Biomarkers | 1 | 2008 | 1718 | 0.050 |
Why?
|
| Spinal Cord | 1 | 2002 | 249 | 0.050 |
Why?
|
| Cesium | 1 | 2001 | 25 | 0.050 |
Why?
|
| Electrodes | 2 | 1991 | 78 | 0.050 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2000 | 10 | 0.050 |
Why?
|
| Cholinergic Agonists | 1 | 2000 | 9 | 0.050 |
Why?
|
| Sexual Behavior | 1 | 2023 | 302 | 0.050 |
Why?
|
| Carbachol | 1 | 2000 | 34 | 0.050 |
Why?
|
| Pons | 1 | 2000 | 24 | 0.050 |
Why?
|
| Ferrets | 1 | 2000 | 47 | 0.050 |
Why?
|
| Calcium Channels, T-Type | 1 | 2000 | 27 | 0.050 |
Why?
|
| Norepinephrine | 1 | 2000 | 167 | 0.050 |
Why?
|
| Calcium Signaling | 1 | 2001 | 129 | 0.050 |
Why?
|
| Magnesium | 1 | 2000 | 177 | 0.050 |
Why?
|
| Choline O-Acetyltransferase | 2 | 1997 | 23 | 0.050 |
Why?
|
| Vision, Monocular | 2 | 2001 | 15 | 0.040 |
Why?
|
| Nicotinic Agonists | 1 | 2000 | 72 | 0.040 |
Why?
|
| Neuroprotective Agents | 1 | 2000 | 94 | 0.040 |
Why?
|
| Periodicity | 1 | 2000 | 119 | 0.040 |
Why?
|
| Haplorhini | 2 | 1976 | 81 | 0.040 |
Why?
|
| Kinetics | 2 | 1996 | 1513 | 0.040 |
Why?
|
| NADPH Dehydrogenase | 2 | 1994 | 11 | 0.040 |
Why?
|
| Shrews | 1 | 1977 | 5 | 0.040 |
Why?
|
| Anti-HIV Agents | 1 | 2020 | 149 | 0.040 |
Why?
|
| Reference Values | 3 | 1994 | 674 | 0.040 |
Why?
|
| Biological Transport, Active | 1 | 1997 | 102 | 0.040 |
Why?
|
| Blindness | 1 | 1977 | 41 | 0.040 |
Why?
|
| Iontophoresis | 1 | 1996 | 9 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1019 | 0.040 |
Why?
|
| Public Sector | 1 | 2016 | 12 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 1996 | 290 | 0.040 |
Why?
|
| Private Sector | 1 | 2016 | 19 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2002 | 2705 | 0.030 |
Why?
|
| Tupaiidae | 1 | 1975 | 1 | 0.030 |
Why?
|
| Strepsirhini | 1 | 1975 | 6 | 0.030 |
Why?
|
| Adaptation, Physiological | 2 | 1994 | 306 | 0.030 |
Why?
|
| Discrimination Learning | 3 | 1983 | 63 | 0.030 |
Why?
|
| Wheat Germ Agglutinins | 2 | 1993 | 16 | 0.030 |
Why?
|
| Electric Conductivity | 2 | 1987 | 144 | 0.030 |
Why?
|
| Career Choice | 1 | 2016 | 139 | 0.030 |
Why?
|
| Bicuculline | 1 | 1994 | 18 | 0.030 |
Why?
|
| Middle Aged | 3 | 2023 | 25028 | 0.030 |
Why?
|
| Sphincter of Oddi Dysfunction | 1 | 2012 | 1 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 1993 | 278 | 0.030 |
Why?
|
| Aged | 2 | 2023 | 18415 | 0.030 |
Why?
|
| Risk Factors | 2 | 2013 | 5417 | 0.030 |
Why?
|
| 2-Amino-5-phosphonovalerate | 1 | 1990 | 11 | 0.020 |
Why?
|
| N-Methylaspartate | 1 | 1990 | 51 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 1990 | 64 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2013 | 454 | 0.020 |
Why?
|
| Eyelids | 2 | 1994 | 23 | 0.020 |
Why?
|
| Valine | 1 | 2009 | 69 | 0.020 |
Why?
|
| Length of Stay | 1 | 2012 | 703 | 0.020 |
Why?
|
| Age Factors | 3 | 1981 | 1851 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2012 | 1823 | 0.020 |
Why?
|
| Adolescent | 1 | 2020 | 8982 | 0.020 |
Why?
|
| Hospitalization | 1 | 2012 | 849 | 0.020 |
Why?
|
| Temporal Lobe | 2 | 1977 | 172 | 0.020 |
Why?
|
| Biophysical Phenomena | 1 | 1986 | 120 | 0.020 |
Why?
|
| Signal Transduction | 1 | 1996 | 3241 | 0.020 |
Why?
|
| Dark Adaptation | 1 | 1984 | 12 | 0.020 |
Why?
|
| Histocytochemistry | 2 | 1994 | 130 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2013 | 4213 | 0.020 |
Why?
|
| Cell Membrane | 1 | 1987 | 666 | 0.010 |
Why?
|
| Adult | 2 | 2013 | 25648 | 0.010 |
Why?
|
| Ganglia | 2 | 1973 | 14 | 0.010 |
Why?
|
| Psychophysics | 1 | 1982 | 80 | 0.010 |
Why?
|
| Growth | 1 | 1982 | 43 | 0.010 |
Why?
|
| Sutures | 1 | 1982 | 52 | 0.010 |
Why?
|
| Photomicrography | 1 | 1981 | 7 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1981 | 408 | 0.010 |
Why?
|
| Biomechanical Phenomena | 1 | 1982 | 457 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2013 | 7993 | 0.010 |
Why?
|
| Form Perception | 1 | 1980 | 36 | 0.010 |
Why?
|
| Arousal | 1 | 2000 | 170 | 0.010 |
Why?
|
| Species Specificity | 1 | 2001 | 678 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2013 | 8491 | 0.010 |
Why?
|
| Nictitating Membrane | 1 | 1977 | 1 | 0.010 |
Why?
|
| Pyramidal Tracts | 1 | 1977 | 16 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 1978 | 217 | 0.010 |
Why?
|
| Cerebral Decortication | 1 | 1975 | 2 | 0.010 |
Why?
|
| Visual Field Tests | 1 | 1975 | 14 | 0.010 |
Why?
|
| Fixation, Ocular | 1 | 1974 | 48 | 0.010 |
Why?
|
| Dogs | 1 | 1975 | 685 | 0.010 |
Why?
|
| Environment | 1 | 1976 | 219 | 0.010 |
Why?
|
| Wheat Germ Agglutinin-Horseradish Peroxidase Conjugate | 1 | 1993 | 4 | 0.010 |
Why?
|
| Suture Techniques | 1 | 1994 | 135 | 0.010 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 1993 | 44 | 0.010 |
Why?
|
| Macula Lutea | 1 | 1973 | 19 | 0.010 |
Why?
|
| Nerve Degeneration | 1 | 1973 | 83 | 0.010 |
Why?
|
| Depth Perception | 1 | 1971 | 19 | 0.010 |
Why?
|
| Light | 1 | 1972 | 289 | 0.010 |
Why?
|
| Mathematics | 1 | 1971 | 190 | 0.010 |
Why?
|
| Darkness | 1 | 1979 | 49 | 0.000 |
Why?
|